Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior ...
The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...
High-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)—plus hormone therapy before and ...
The 2026 SNMMI annual meeting featured a genitourinary diagnosis and imaging session, including a presentation by Dr. Surekha Yadav discussing longitudinal outcomes of PSMA PET/CT-detected bone ...
Radium-223 is an α-emitting radiopharmaceutical that improves survival in metastatic castration-resistant prostate cancer (mCRPC). Preclinical data suggest synergy between poly(ADP-ribose) polymerase ...
Former President Joe Biden has been diagnosed with an aggressive form of prostate cancer, with metastasis to the bone, according to a statement from his personal office Sunday. Doctors diagnosed Biden ...
The US Food and Drug Administration (FDA) has granted priority review to Bayer HealthCare's New Drug Application (NDA) which was filed in December 2012 for the investigational oncology compound radium ...
SurvivorNet on MSN
ASCO 2026: A major prostate cancer trial shows drug can keep high-risk disease from returning for longer
Data from the PROTEUS trial showed that adding a hormone-blocking pill called apalutamide to standard hormone therapy, both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results